Janis Chamberlain

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Reactive Oxygen Species

Top Venues

Science signaling

Journal of paediatrics and child health

This page only lists publications with an associated author ORCID identifier.

Publications

Zacary P Germon, Jonathan R Sillar, Abdul Mannan, Ryan J Duchatel, Dilana E Staudt, Heather C Murray, Izac J Findlay, Evangeline R Jackson, Holly P McEwen, Alicia M Douglas, Tabitha McLachlan, John E Schjenken, David A Skerrett-Byrne, Honggang Huang, Marcella Nunes de Melo-Braga, Maximilian W Plank, Frank Alvaro, Janis Chamberlain, Geoffry N De Iuliis, Robert John Aitken, Brett Nixon, Andrew H Wei, Anoop K Enjeti, Yizhou Huang, Richard B Lock, Martin Røssel Larsen, Heather J Lee, Vijesh Vaghjiani, Jason E Cain, Charles E de Bock, Nicole M Verrills, Matthew D Dun
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies. Science signaling 16 (778) (2023)
Zacary P Germon, Jonathan R Sillar, Abdul Mannan, Ryan J Duchatel, Dilana E Staudt, Heather C Murray, Izac J Findlay, Evangeline R Jackson, Holly P McEwen, Alicia M Douglas, Tabitha McLachlan, John E Schjenken, David A Skerrett-Byrne, Honggang Huang, Marcella Nunes de Melo-Braga, Maximilian W Plank, Frank Alvaro, Janis Chamberlain, Geoffry N De Iuliis, Robert John Aitken, Brett Nixon, Andrew H Wei, Anoop K Enjeti, Yizhou Huang, Richard B Lock, Martin Røssel Larsen, Heather J Lee, Vijesh Vaghjiani, Jason E Cain, Charles E de Bock, Nicole M Verrills, Matthew D Dun
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies. Science signaling 16 (778) (2023)
Vanessa Verissimo, Tina Carter, Helen Wright, Jeremy Robertson, Michael Osborn, Peter Bradbeer, Vanaja Sabesan, Ben Saxon, Pasquale Barbaro, Gemma Crighton, Janis Chamberlain, Silvia Zheng, Kate Freeman
Australian and New Zealand consensus guideline for paediatric newly diagnosed immune thrombocytopaenia endorsed by Australian New Zealand Children's Haematology and Oncology Group. Journal of paediatrics and child health (2023)